Uniplan Investment Counsel, Inc. Amgen Inc Transaction History
Uniplan Investment Counsel, Inc.
- $1.1 Billion
- Q2 2024
A detailed history of Uniplan Investment Counsel, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Uniplan Investment Counsel, Inc. holds 10,210 shares of AMGN stock, worth $3.23 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
10,210
Previous 10,442
2.22%
Holding current value
$3.23 Million
Previous $2.97 Million
7.44%
% of portfolio
0.29%
Previous 0.23%
Shares
3 transactions
Others Institutions Holding AMGN
# of Institutions
3,073Shares Held
417MCall Options Held
7.19MPut Options Held
6.28M-
Vanguard Group Inc Valley Forge, PA51.9MShares$16.4 Billion0.32% of portfolio
-
Black Rock Inc. New York, NY46MShares$14.5 Billion0.33% of portfolio
-
State Street Corp Boston, MA29MShares$9.15 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA14.4MShares$4.57 Billion3.32% of portfolio
-
Morgan Stanley New York, NY14.4MShares$4.54 Billion0.35% of portfolio
About AMGEN INC
- Ticker AMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 534,931,008
- Market Cap $169B
- Description
- Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...